• Skip to primary navigation
  • Skip to main content
  • Skip to footer
NICO CorporationSecondary logo

NICO Corporation

Dedicated to revolutionizing minimally invasive neurosurgery

  • Home
  • Patients
  • Professionals
    • Our Capabilities
    • Our Integrated System
    • Our Surgical Focus
    • Our Impact
    • Published Data
    • Investigator Initiated Study Program
      • IIS Program Overview
      • IIS Areas of Interest (AOIs)
    • Donation Request
    • Global Distribution
    • NICO Technologies for Animal Health
    • Neurosurgeon Education
  • Company
    • Our Mission
    • Our Leadership Team
    • News & Events
    • Careers
  • LinkedIn
  • Twitter
  • YouTube

NICO Announces New Distributor for Australia and New Zealand Markets

Home » NICO Announces New Distributor for Australia and New Zealand Markets

July 18, 2022 by admin

For Immediate Release

Contact: Sue Goin
sue.goin@sapphire-com
317.402.8690

Download Press Release (PDF)

Indianapolis (June 27, 2022) – Medical device innovator NICO Corporation announced today that it has partnered with Imedcare, Australia-based supplier and distributor of devices specializing in neurosurgery for the Australia and New Zealand neurosurgery medical sector.

“We look forward to expanding access to NICO’s innovative technologies in this region through our exclusive distribution partnership with Imedcare,” said Steve Ball, General Manager for International markets and U.S. Western Region Sales Director. “Their team has several years of experience in neurosurgery, which will further strengthen our product awareness and adoption in Australia and New Zealand and more importantly, offer surgeons the opportunity to positively affect patient outcomes.”

NICO is an evidence- and outcomes-based company dedicated to enabling new surgical options for brain abnormalities (some of which might have previously been inoperable) and the ability to create access for direct delivery of novel therapeutics and for the emerging world of brain implants. Its technologies have been featured in more than 175 peer-reviewed published papers with over 550 unique authors from major academic centers.

NICO currently holds over 250 issued or pending patents, with 60 focusing solely on safe and repeatable non-disruptive access through eloquent areas of the brain with NICO BrainPath®, efficient removal of tumors and clots down a small corridor using the NICO Myriad®, and collection and biological preservation of tumor tissue in the operating room with the Automated Preservation System®. It is the first company to develop and patent technologies to create an entirely new minimally invasive surgical market in neurosurgery for subcortical and skull base lesions, including hemorrhagic stroke – the most costly, deadly and debilitating form of stroke with no surgical solution to date.

Learn about NICO technologies at NICOneuro.com; follow news updates on LinkedIn and Twitter, and view surgical and patient videos on YouTube at NICOneuroCorp.

Press Release

Footer

OUR MISSION is SIMPLE

We provide proven and patented technologies that integrate imaging and intervention for a safe, minimally disruptive approach to brain surgery. This integration drives efficiencies for the patient, surgeon and healthcare provider.

Customer Service

 Tel: (317) 660-7118
 Email Us

Follow NICO Here

  • LinkedIn
  • Twitter
  • YouTube
Social Media Links

Search Our Website

privacy policy   ·    terms of use   ·    patents    ·   labeling

Copyright © 2023 · Nico Corporation · NICO Myriad and BrainPath are “tools” not “treatments”. Physicians should use their best judgment and clinical experience when deciding how to use the Myriad and BrainPath. The latest information, including contraindications, warnings and precautions can be obtained by consulting product labeling or your local NICO representative.